146 related articles for article (PubMed ID: 14629129)
1. Serum hyaluronan: a marker of liver fibrosis in patients with chronic liver disease.
Tangkijvanich P; Kongtawelert P; Pothacharoen P; Mahachai V; Suwangool P; Poovorawan Y
Asian Pac J Allergy Immunol; 2003 Jun; 21(2):115-20. PubMed ID: 14629129
[TBL] [Abstract][Full Text] [Related]
2. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
[TBL] [Abstract][Full Text] [Related]
3. [The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease].
Kwon JH; Park ST; Kim GD; You CR; Kim JD; Woo HY; Jang JW; Kim CW; Bae SH; Choi JY; Yoon SK
Korean J Hepatol; 2009 Mar; 15(1):59-69. PubMed ID: 19346786
[TBL] [Abstract][Full Text] [Related]
4. Increased Red Cell Distribution Width is Strong Inflammatory Marker of Liver Diseases in a Guangxi Population.
Lan F; Wei H; Zhu X; Li S; Qin X
Clin Lab; 2017 Feb; 63(2):389-398. PubMed ID: 28182351
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis.
Guéchot J; Laudat A; Loria A; Serfaty L; Poupon R; Giboudeau J
Clin Chem; 1996 Apr; 42(4):558-63. PubMed ID: 8605673
[TBL] [Abstract][Full Text] [Related]
6. [Prediction of hepatic fibrosis using serum hyaluronic acid in patients with chronic liver disease].
Kim CW; Yoon SK; Jo BS; Shin JY; Jang JW; Choi JY; Han NI; Lee CD; Chung KW; Sun HS
Korean J Gastroenterol; 2003 Dec; 42(6):510-8. PubMed ID: 14695708
[TBL] [Abstract][Full Text] [Related]
7. Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits.
Spadaro A; Ajello A; Morace C; Zirilli A; D'arrigo G; Luigiano C; Martino F; Bene A; Migliorato D; Turiano S; Ferraù O; Freni MA
World J Gastroenterol; 2005 Apr; 11(13):1987-90. PubMed ID: 15800991
[TBL] [Abstract][Full Text] [Related]
8. [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma].
Zhao XY; Li N; Ding HG; Jiang FF
Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):943-5. PubMed ID: 21223806
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P
J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164
[TBL] [Abstract][Full Text] [Related]
10. Assessment of liver fibrosis development in chronic hepatitis B patients by serum hyaluronic acid and laminin levels.
Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D
Acta Clin Croat; 2010 Sep; 49(3):257-65. PubMed ID: 21462814
[TBL] [Abstract][Full Text] [Related]
11. Serum surrogate markers of liver fibrosis in primary biliary cirrhosis.
Voumvouraki A; Koulentaki M; Notas G; Sfakianaki O; Kouroumalis E
Eur J Intern Med; 2011 Feb; 22(1):77-83. PubMed ID: 21238899
[TBL] [Abstract][Full Text] [Related]
12. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
Yilmaz S; Bayan K; Tüzün Y; Dursun M; Kaplan A; Ozmen S; Canoruç F; Akkuş Z
Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
[TBL] [Abstract][Full Text] [Related]
13. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
[TBL] [Abstract][Full Text] [Related]
14. Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C.
Patel K; Lajoie A; Heaton S; Pianko S; Behling CA; Bylund D; Pockros PJ; Blatt LM; Conrad A; McHutchison JG
J Gastroenterol Hepatol; 2003 Mar; 18(3):253-7. PubMed ID: 12603524
[TBL] [Abstract][Full Text] [Related]
15. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract][Full Text] [Related]
16. Serum hyaluronic acid as a marker of hepatic fibrosis.
Khan JA; Khan FA; Dilawar M; Ijaz A; Khan NA; Mehmood T
J Coll Physicians Surg Pak; 2007 Jun; 17(6):323-6. PubMed ID: 17623578
[TBL] [Abstract][Full Text] [Related]
17. Correlation between Serum Hyaluronic Acid with Steatosis, Non alcoholic Steato-hepatitis and Fibrosis in Patients with Chronic Hepatitis C Virus Infection.
Mahmoud HS; Ghweil AAS; Osman GS; Ezz-Eldin S Bazeed S; Helal MM
Trop Gastroenterol; 2016; 37(2):93-100. PubMed ID: 30234278
[TBL] [Abstract][Full Text] [Related]
18. Soluble Vascular Endothelial Growth Factor Receptor-2 as a Predictive Factor for Progression of Illness in Chronic Liver Diseases and Hepatocellular Carcinoma.
Ratnasari N; Nurdjanah S; Sadewa AH; Hakimi M; Yano Y
Kobe J Med Sci; 2015 Dec; 61(3):E89-96. PubMed ID: 27323788
[TBL] [Abstract][Full Text] [Related]
19. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma.
Hayasaka A; Suzuki N; Fujimoto N; Iwama S; Fukuyama E; Kanda Y; Saisho H
Hepatology; 1996 Nov; 24(5):1058-62. PubMed ID: 8903375
[TBL] [Abstract][Full Text] [Related]
20. Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.
Tangkijvanich P; Tosukhowong P; Bunyongyod P; Lertmaharit S; Hanvivatvong O; Kullavanijaya P; Poovorawan Y
Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):110-4. PubMed ID: 10695798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]